Zenotere 20 MG Injection 0.5 ML

Zenotere 20 MG Injection 0.5 ML is used for the following:

• Managing locally advanced or metastatic breast cancer, after previous chemotherapy has failed.

• As a part of combo therapy involving doxorubicin and cyclophosphamide, for operable node-positive breast cancer.

• Controlling locally advanced or metastatic non-small cell lung cancer (NSCLC), after platinum-based therapy failure.

• Working with cisplatin to manage NSCLC in patients who are new to chemotherapy.

• Handling hormone-refractory metastatic prostate cancer, alongside prednisone.

• Combating advanced gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, in conjunction with cisplatin and fluorouracil for previously untreated patients.

• Managing locally advanced squamous cell carcinoma of the head and neck (SCCHN), in combination with cisplatin and fluorouracil as part of induction therapy.

Administer Zenotere 20 MG Injection 0.5 ML as suggested below:

• This medicine is administered intravenously under the supervision of a doctor.

• The injection must be given as a one-hour infusion every three weeks.

• It's important to receive this medicine only in a facility equipped to handle potential complications.

• The dosage depends on your health condition, body surface area and overall health status.

• Always consult your doctor for specific advice on administering this medicine.

Zenotere 20 MG Injection 0.5 ML is administered intravenously.

Zenotere 20 MG Injection 0.5 ML contains Docetaxel (20 mg) which works on your body in the following ways:

• Promotes Assembly of Microtubules: Docetaxel encourages the assembly of tubulin into stable microtubules in your body's cells.

• Inhibits Disassembly: At the same time, it inhibits disassembly, maintaining the stability of these microtubules.

• Impairs Cellular Functions: By stabilising microtubules, docetaxel effectively impairs mitotic and interphase cellular functions which are key stages in a cell's life cycle.

• Induces Abnormal Arrays: Additionally, docetaxel induces abnormal arrays or "bundles" of microtubules throughout a cell cycle and multiple asters of microtubules during mitosis.

• Keep Zenotere 20 MG Injection 0.5 ML stored at room temperature.

• Protect the medicine from light by keeping it in the original packaging until you need to use it.

• Ensure the injection is kept out of reach of children.

• Make sure to use Zenotere 20 MG Injection 0.5 ML before its expiry date.

• Regularly consume foods rich in iron, like spinach and beans, to help manage anaemia—a common side effect in cancer patients undergoing chemotherapy with Zenotere 20 MG Injection 0.5 ML.

• Engage in gentle exercises such as walking or yoga, as appropriate for your condition, to combat fatigue—another side effect experienced by many cancer patients. Please consult your doctor before starting any exercise regimen.